Analytical Data
-
基因名
SPTLC3
- Application
-
别名
SPTLC3；C20orf38；SPTLC2L；Serine palmitoyltransferase 3
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9NUV7
-
表达区间
1-552aa
-
氨基酸序列
MANPGGGAVCNGKLHNHKKQSNGSQSRNCTKNGIVKEAQQNGKPHFYDKLIVESFEEAPLHVMVFTYMGYGIGTLFGYLRDFLRNWGIEKCNAAVERKEQKDFVPLYQDFENFYTRNLYMRIRDNWNRPICSAPGPLFDLMERVSDDYNWTFRFTGRVIKDVINMGSYNFLGLAAKYDESMRTIKDVLEVYGTGVASTRHEMGTLDKHKELEDLVAKFLNVEAAMVFGMGFATNSMNIPALVGKGCLILSDELNHTSLVLGARLSGATIRIFKHNNTQSLEKLLRDAVIYGQPRTRRAWKKILILVEGVYSMEGSIVHLPQIIALKKKYKAYLYIDEAHSIGAVGPTGRGVTEFFGLDPHEVDVLMGTFTKSFGASGGYIAGRKDLVDYLRVHSHSAVYASSMSPPIAEQIIRSLKLIMGLDGTTQGLQRVQQLAKNTRYFRQRLQEMGFIIYGNENASVVPLLLYMPGKVAAFARHMLEKKIGVVVVGFPATPLAEARARFCVSAAHTREMLDTVLEALDEMGDLLQLKYSRHKKSARPELYDETSFELED
-
分子量
62 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SPTLC3 (serine palmitoyltransferase long chain base subunit 3) is a crucial enzyme involved in sphingolipid metabolism, which plays a vital role in various cellular processes, including membrane formation, signaling, and cell growth. Dysregulation of sphingolipid metabolism has been implicated in several diseases, such as cancer, neurodegenerative disorders, and metabolic syndromes. Research on SPTLC3 has gained significant attention due to its potential implications in understanding these diseases and the development of therapeutic strategies. The recombinant expression of SPTLC3 allows for detailed structural and functional studies of the protein, facilitating investigations into its enzymatic activity and interaction with other cellular components. Additionally, the study of SPTLC3 can provide insights into the regulatory mechanisms governing sphingolipid biosynthesis and how its dysfunction contributes to pathophysiological conditions. By producing recombinant SPTLC3, researchers aim to elucidate its role in sphingolipid metabolism, providing a foundation for exploring its potential as a therapeutic target in associated diseases.
